• Users Online: 800
  • Print this page
  • Email this page


 
 
Table of Contents
LETTER TO THE EDITOR
Year : 2019  |  Volume : 30  |  Issue : 1  |  Page : 40-41

Untreated urinary bladder stone and subsequent squamous cell carcinoma


1 Department of Urology, Mackay Memorial Hospital, Taipei, Taiwan
2 Department of Medicine, Mackay Medical College, Taipei, Taiwan
3 Department of Cosmetic Applications and Management, Mackay Junior College of Medicine, Nursing, and Management, Taipei, Taiwan

Date of Web Publication2-Jan-2019

Correspondence Address:
Marcelo Chen
Department of Urology, Mackay Memorial Hospital, No. 92, Section 2, Zhongshan North Road, Zhongshan District, Taipei 104
Taiwan
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/UROS.UROS_16_17

Get Permissions


How to cite this article:
Tseng JS, Chen M, Lin WC. Untreated urinary bladder stone and subsequent squamous cell carcinoma. Urol Sci 2019;30:40-1

How to cite this URL:
Tseng JS, Chen M, Lin WC. Untreated urinary bladder stone and subsequent squamous cell carcinoma. Urol Sci [serial online] 2019 [cited 2019 Jan 19];30:40-1. Available from: http://www.e-urol-sci.com/text.asp?2019/30/1/40/228285



Dear Editor,

A 67-year-old male visited our outpatient department with the chief complaint of gross hematuria for a long time. He was diagnosed with a large bladder stone for more than 20 years, but he refused surgery. The stone size increased gradually year-by-year and reached 8.7 cm during the latest visit. The patient finally agreed to surgery due to intractable hematuria. During cystolithotomy [Figure 1], diffusely thickened bladder wall and a wide-based tumor were seen. Biopsy was performed and showed low-grade squamous cell carcinoma (SCC), which at least invaded the subepithelial connective tissue. Computed tomography showed an irregular tumor involving the anterior bladder wall, peritoneal metastatic tumors, and a lymph node in the left pelvic sidewall [Figure 2] and [Figure 3]. Chemotherapy with gemcitabine and cisplatin was started immediately after the diagnosis. However, obstructive uropathy and bowel obstruction developed rapidly despite chemotherapy. He died of intra-abdominal infection-related sepsis 6 months later.
Figure 1: The stone fragments. The stone was partially disintegrated during the operation in hope to minimize the abdominal incision

Click here to view
Figure 2: Computed tomography of the abdomen. Computed tomography revealed a 3.8 cm × 10.0 cm irregular tumor involving anterior bladder wall (a) and a 3.7 cm × 1.6 cm lymph node in the left pelvic sidewall (arrow)

Click here to view
Figure 3: Computed tomography of the abdomen. Computed tomography revealed a 3.8 cm × 10.0 cm irregular tumor involving anterior bladder wall (a) and a 3.2 cm × 9.2 cm peritoneal metastatic tumor (b)

Click here to view


As a variant malignancy of the urinary tract other than urothelial carcinoma, SCC is rarely seen, but it frequently presents in an advanced stage at diagnosis. The development of SCC of the bladder can be separated into bilharzia SCC and nonbilharzia (NB-SCC) on etiology. SCC accounts for <5% of bladder malignancies but can account for up to 60% in the schistosomiasis-endemic regions. The predisposing factors of bladder NB-SCC include tobacco smoking, chronic infection, long-term indwelling catheterization, bladder outlet obstruction, and as in our case, urolithiasis. Chronic inflammation caused by these predisposing factors may facilitate proliferation, metaplasia, and malignant change of the bladder epithelium. The prominent symptom of bladder SCC is hematuria, while irritative symptoms occur in some cases.[1] A subanalysis using the Surveillance, Epidemiology, and End Result registries database found that more than 85% of SCCs presented as muscle-invasive tumors in contrast to 22% of urothelial carcinomas (UC).[2] The study found comparable 2-year overall survival and cancer-specific survival between localized SCC and UC after radical cystectomy. In higher-staged tumors with radical cystectomy and in all-stage tumors without radical cystectomy, the 2-year overall survival and cancer-specific survival were better in the UC group. A later study using the same database in patients receiving radical cystectomy did not find differences in 5-year cancer-specific mortality between the different pathological subtypes.[3] These results support the role of radical cystectomy as the standard treatment. Other treatment choices include radiation and chemotherapy. The optimal treatment modalities and the efficacy of these treatments remain controversial due to the small case numbers, and treatments other than radical cystectomy seem to be less effective.[1] Lin et al. inspected the relationship between urolithiasis and intervention with subsequent cancer development using a population-based database. After reviewing 42,732 participants with a history of urolithiasis using the National Health Insurance Research Database in Taiwan, they found a 1.82-fold increased risk of developing urinary tract cancer. Furthermore, patients who received early intervention (within 3 months) had a decreased risk of subsequent urinary tract cancers (adjusted hazard ratio: 0.53, 95% confidence interval: 0.40–0.71, P < 0.001).[4]

In conclusion, untreated bladder stones may lead to the development of bladder SCC. Early intervention for bladder stones is therefore recommended.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Martin JW, Carballido EM, Ahmed A, Farhan B, Dutta R, Smith C, et al. Squamous cell carcinoma of the urinary bladder: Systematic review of clinical characteristics and therapeutic approaches. Arab J Urol 2016;14:183-91.  Back to cited text no. 1
    
2.
Scosyrev E, Yao J, Messing E. Urothelial carcinoma versus squamous cell carcinoma of bladder: Is survival different with stage adjustment? Urology 2009;73:822-7.  Back to cited text no. 2
    
3.
Abdollah F, Sun M, Jeldres C, Schmitges J, Thuret R, Djahangirian O, et al. Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs. urothelial carcinoma: A competing-risks analysis. BJU Int 2012;109:564-9.  Back to cited text no. 3
    
4.
Lin CL, Huang WT, Fan WC, Feng YH, Lin CH, Lin CS, et al. Associations between interventions for urolithiasis and urinary tract cancer among patients in Taiwan: The effect of early intervention. Medicine (Baltimore) 2016;95:e5594.  Back to cited text no. 4
    


    Figures

  [Figure 1], [Figure 2], [Figure 3]



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
References
Article Figures

 Article Access Statistics
    Viewed509    
    Printed70    
    Emailed0    
    PDF Downloaded65    
    Comments [Add]    

Recommend this journal